Covidien's robust health in dire times is down to "sticking to the basics"
This article was originally published in Clinica
Executive Summary
In the fourth instalment of Clinica's Industry Leaders series, Peter Wehrly, group president of Covidien's respiratory and vascular businesses, discusses how the company has been weathering the economic storm and its strategy for keeping ahead of the game. Tina Tan reports